Ignite Creation Date:
2025-12-18 @ 5:49 AM
Ignite Modification Date:
2025-12-23 @ 8:46 PM
Study NCT ID:
NCT00753506
Status:
None
Last Update Posted:
2012-02-28 00:00:00
First Post:
2008-09-15 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Artemisinin to Reduce The Symptoms of Schizophrenia
Sponsor:
None
Organization:
Study Overview
Official Title:
Double-Blind Trial of Artemisinin to Reduce The Symptoms of Schizophrenia
Status:
None
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aims of the current study are:
1. To evaluate the efficacy and side effects of artemisinin as an add-on compound for patients with schizophrenia who have residual psychotic symptoms of at least moderate severity.
2. To evaluate the effect of artemisinin on cognitive impairments and associated functional skills.
3. To investigate whether treatment with artemisinin produces a significant effect on the levels of antibodies to Toxoplasma.
4. To examine whether changes in cognitive impairment or psychiatric symptoms are correlated with changes in antibodies to Toxoplasma before and during the treatment with artemisinin.
1. To evaluate the efficacy and side effects of artemisinin as an add-on compound for patients with schizophrenia who have residual psychotic symptoms of at least moderate severity.
2. To evaluate the effect of artemisinin on cognitive impairments and associated functional skills.
3. To investigate whether treatment with artemisinin produces a significant effect on the levels of antibodies to Toxoplasma.
4. To examine whether changes in cognitive impairment or psychiatric symptoms are correlated with changes in antibodies to Toxoplasma before and during the treatment with artemisinin.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: